Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed Nov 19, 2025 · 10-Q · 50 days after period end · 0001477932-25-008494
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | $2.23M | -$372.22K | -$342.01K | -$4.82M |
| EPS Diluted | $0.00 | $0.00 | — | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 19, 2025 · 50 d after period end
